ARCHIVES

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

This article is from The Cancer Letter archive.

Vol. 05 No. 43 | October 26, 1979

Download PDF Visit The Full Archive

Related Articles

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009

In Brief: Julie Vose Was Elected President of the American Society of Clinical Oncology

January 3, 2014

Natcher Subcommittee Open Door To justification for Increasing Cancer Program 1982 Appropriation

April 3, 1981

Communication Is Key To Clinical Trial Enrollment

June 30, 2006